Latest News

First patient randomised in the phase 3 NODE-301 trial evaluating etripamil

Milestone Pharmaceuticals, a clinical-stage cardiovascular company, announced that the first patient has been randomised in its phase 3 clinical study of etripamil. Etripamil is...

Medtronic begins pilot study of investigational extravascular ICD system

Re-evaluate use of anticoagulation in patients with atrial flutter

VisONE system for heart failure implanted for first time

The rise of smartphones and wearables for AF detection: WATCH-AF and...

Features

Cybersecurity safety communications for implantable cardiac devices: Year in review

Cyber security has become a hot topic in recent years. Leslie Saxon writes in Cardiac Rhythm News about the cybersecurity risks for implantable cardiac...

Stroke – the need for interdisciplinary concepts

The link between cardiac diseases and stroke is well known and reported. Wolfram Döhner writes in Cardiac Rhythm News about the needs for interdisciplinary...

Videos

Treating sleep apnoea in pacemaker patients improves AF therapy

This video has been sponsored by LivaNova. Sleep apnoea is a major chronic disease that can have cardiovascular consequences. Around 40–50% of people with atrial fibrillation (AF) have obstructive sleep apnoea, rising to around 60% in patients with implantable cardiac...

Events

Dhanunjaya Lakkireddy

Luigi Di Biase

Nassir Marrouche

(Visited 24,110 times, 16 visits today)
Cardiac Rhythm News

Write to us
Editor: Hannah Woolley hannah@bibamedical.com
Advertising: Noora Lobo noora@bibamedical.com

BIBA Medical Ltd, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 EMAIL: info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.

Terms and Conditions | Privacy Policy